Učinak pentadekapeptida BPC 157 i losartana na nefrotoksičnost epirubicina u eksperimentalnih životinja

Ćorić-Martinović, Valentina (2012) Učinak pentadekapeptida BPC 157 i losartana na nefrotoksičnost epirubicina u eksperimentalnih životinja. PhD thesis, Sveučilište u Zagrebu.

[img]
Preview
PDF
Download (2MB) | Preview

Abstract

We focused on epirubicin induced progressive renal failure and the effects of stable gastric pentadecapeptide BPC 157 and losartan. In rats and mouses epirubicin 5 mg/kg was used intraperitoneally. Thereafter, all the animals were randomly assigned for two subsequent protocols: in co-treatment protocol with treatment started immediatly after randomisation and in post-treatment protocol with treatment started 7 days after epirubicin injection. We used for medication: losartan (1 mg/kg and 10 mg/kg) and BPC 157 (10 pg/kg, 10 ng/kg, 10 micro g/kg) given intragastric once daily (rats) or in drinking water (mice, 2 ml/mouse daily), while controls received an equivolumen of distilled water (rats, 5.0 ml/kg, i.g.) or drinking water (mice). The animals were sacrificed 28 days after epirubicin application. Seven days following epirubicin regimen, control animals (without treatment) have a signs of nephrotic syndrome (proteinuria, hyperlipidaemia and edema) with specific differences between species. These signs developed in control groups in 14. and 28. day. Losartan showed expected beneficial effects on signs of nephrotic syndrome. BPC 157 showed better and more rapid effect than losartan on hystopathological changes, proteinuria, hyperlipidaemia and edema in present study. Control animals had focal epitel necrosis of proximal tubule in significantly higher stage then animals treated with losartan. Animals treated with BPC 157 did not have pathological changes. These results are in correlation with beneficial effect of BPC-157 on doxorubicine induced congestive heart failure and suggest use of BPC 157 in treatment of nephrotic syndrome.

Abstract in Croatian

U radu su prikazani učinci pentadekapeptida BPC 157 i losartana u eksperimentalnom modelu nefrotskog sindroma izazvanog primjenom epirubicina u štakora i miša. Nefrotski sindrom izazvan je jednokratnom intraperitonealnom primjenom epirubicina u dozi od 5 mg/kg TT. Eksperimentalne životinje su podijeljene u dvije skupine: kotretman, za koje je tretman započeo neposredno nakon aplikacije epirubicina, i posttretman, za kojih je tretman započeo 7 dana nakon aplikacije epirubicina. Životinje su svakodnevno tretirane intragastrički (štakori) ili u vodi za piće (miševi) losartanom u dozama 1 mg/kg i 10 mg/kg i pentadekapeptidom u dozama BPC-a 157 10 pg/ml, 10 ng/ml i 10 mikro g/kg, a žrtvovane su 28 dana nakon aplikacije epirubicina. Dobiveni su sljedeći rezultati: u kontrolnim skupinama neliječene su životinje imale izražene znakove nefrotskog sindroma u smislu edema s proteinurijom i hiperlipidemijom u značajno većoj mjeri od tretiranih životinja. Losartan je pokazao očekivani povoljan učinak na te znakove nefrotskog sindroma. BPC 157 je pokazao bolji i raniji učinak na proteinuriju i posljedične periferne edeme te hiperlipidemiju od losartana. Učinci su bili izraženiji primjenom mikrogramske doze. Histopatološka analiza također je pokazala povoljan učinak BPC-a 157 na potpuni izostanak promjena, a losartana na značajno manju pojavu promjena u usporedbi s kontrolom. Ti su rezultati u korelaciji s povoljnim učinkom BPC-a 157 na doksorubicinom izazvano kongestivno srčano zatajenje i sugeriraju njegovu upotrebu u liječenju nefrotskog sindroma.

Item Type: Thesis (PhD)
Mentors:
Mentor
Šeparović Hanževački, Jadranka
Departments: Izvan medicinskog fakulteta
Depositing User: Marijan Šember
University: Sveučilište u Zagrebu
Institution: Medicinski fakultet
Number of Pages: 88
Status: Unpublished
Creators:
CreatorsEmail
Ćorić-Martinović, ValentinaUNSPECIFIED
Date: 7 March 2012
Date Deposited: 13 Apr 2012 08:44
Last Modified: 13 Apr 2012 08:48
Subjects: /
Related URLs:
    URI: http://medlib.mef.hr/id/eprint/1592

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year